The recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, has resulted in renewed ...

New research highlights the potential of the protein BCL6 in preserving muscle mass, especially when used with popular weight ...

Dr. Karan Rajan responds to Oprah Winfrey's insights on thin people, highlighting the complex biology behind obesity, beyond just willpower.

Even really skinny people like to be on Ozempic, especially these people in Hollywood because they don’t get hungry,” says one plastic surgeon.

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...

Food noise, the constant thought or internal chatter about food, is gaining visibility amid increased understanding and ...

With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...

The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.